AGP Picks
View all

Puerto Rico Healthcare Daily
Provided by AGP

Puerto Rico Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Healthcare Daily.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 22, 2026

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
Jul. 22, 2026

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Indeterminate GlobeNewswire
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
Jul. 22, 2026

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

Indeterminate GlobeNewswire
uniQure to Announce Second Quarter 2026 Financial Results
Jul. 22, 2026

uniQure to Announce Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
Jul. 22, 2026

Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune

Indeterminate GlobeNewswire
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
Jul. 22, 2026

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

Indeterminate GlobeNewswire
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
Jul. 22, 2026

Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
Jul. 22, 2026

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

Indeterminate GlobeNewswire
Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026
Jul. 22, 2026

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire
BioCryst to Report Second Quarter 2026 Financial Results on August 5
Jul. 22, 2026

BioCryst to Report Second Quarter 2026 Financial Results on August 5

Indeterminate GlobeNewswire
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
Jul. 22, 2026

Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy

Indeterminate GlobeNewswire
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
Jul. 22, 2026

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer

Indeterminate GlobeNewswire
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Jul. 22, 2026

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman

Indeterminate GlobeNewswire
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul. 22, 2026

Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire
Supportive Cancer Care Takes Center Stage as Members of the National Coalition Together for Supportive Cancer Care Ring the Nasdaq Closing Bell
Jul. 22, 2026

Supportive Cancer Care Takes Center Stage as Members of the National Coalition Together for Supportive Cancer Care Ring the Nasdaq Closing Bell

Indeterminate GlobeNewswire
ReBio Pharma appoints leading ocular oncologist Professor Mandeep Sagoo as Chief Medical Officer
Jul. 22, 2026

ReBio Pharma appoints leading ocular oncologist Professor Mandeep Sagoo as Chief Medical Officer

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
Jul. 22, 2026

Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
GlycoReset Supplement Facts Released: Consumer Safety Report Details New Analysis About Glyco Reset Ingredients & Side Effects Risk
Jul. 22, 2026

GlycoReset Supplement Facts Released: Consumer Safety Report Details New Analysis About Glyco Reset Ingredients & Side Effects Risk

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Puerto Rico Healthcare Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.